Better Detection, Better Returns: The Financial and Clinical Power of Detecting Cognitive Decline Early with Canary Speech

As America’s senior population continues to grow, so do the clinical and financial challenges posed by cognitive decline. Cutting-edge speech analytics now offer healthcare systems a proactive approach, one that not only transforms early detection of Mild Cognitive Impairment (MCI) but also unlocks substantial, ongoing savings by preventing progression to Alzheimer’s Disease Related Dementia (ADRD). Read more about the accuracy of our model in this peer-reviewed article.
The Opportunity: Early Detection, Proven Impact
22% of Americans aged 65+ live with MCI. Of these, 37.9% will develop ADRD within one year of diagnosis, while 62.1% remain as stable MCI during that time. In a cohort of 1,000 seniors, nearly 834 individuals may progress to costlier ADRD care within a year unless innovative, early interventions are deployed.1
Canary Speech enables providers to seamlessly integrate reimbursable cognitive and behavioral assessments into their standard workflows. Utilizing established CPT® codes, providers can conduct scalable, evidence-based screenings and monitoring, ensuring both clinical rigor and revenue integrity. For example:
- A brief emotional/behavioral assessment or an automated, voice-based cognitive assessment may be reimbursed under CPT® 96127 and CPT® 96146.
- When extended evaluations are medically indicated, they may be reimbursed under CPT® codes 96112 and 96125, bringing significant direct revenue to practices that embrace routine, proactive cognitive screening.
How Canary Speech Delivers Real Savings
Through AI-driven speech analytics, Canary Speech identifies subtle vocal biomarkers indicating cognitive decline, often long before traditional clinical signs emerge. By enabling providers to identify at-risk patients sooner, care teams can:
- Target interventions before acute events like emergency department (ED) visits or hospitalizations occur.
- Engage patients and families in care planning early, delaying transitions to more intensive and expensive care settings.
These proactive efforts are not only clinically impactful but are also billable. Canary Speech assessments, when billed as secondary or supplemental services using appropriate CPT® codes, generate new revenue streams while supporting a conservative 10% reduction in total cost of care. For every 1,000 patients aged 65+ engaged with Canary’s approach, this means $18.7 million in yearly savings, coupled with consistent, reimbursable clinical encounters.
The Science and Savings, Validated
The economics are clear and compelling. As demonstrated in large-scale, peer-reviewed studies:
- Annual costs leap dramatically once MCI transitions to ADRD. Prevention or delay of this progression is critical for bending the healthcare cost curve.2 3
- Canary Speech’s technology offers a scalable, non-invasive, and patient-friendly tool for ongoing monitoring.4 Because uses may be covered under established CPT® billing pathways, organizations can sustain high-touch, proactive care without absorbing unreimbursed costs.
Why Canary’s Savings Are Constant
Unlike sporadic medical breakthroughs or one off treatments, the value of improved detection and tailored proactive care accumulates annually: every year a patient avoids advancing to ADRD is another year of considerable cost savings for healthcare systems, payors, and families. With Canary Speech, providers are empowered to deliver these savings year after year without financial compromise, using recognized billing codes to maintain both workflow efficiency and revenue integrity.
By embedding precise, scalable speech analytics into routine care, we give organizations a powerful, sustainable tool for cognitive health monitoring. With Canary Speech, the future of cognitive health management is proactive, data-driven, and economically advantageous for all stakeholders. The path to constant, enduring healthcare savings runs directly through innovative, voice-based early detection.
For a full list of applicable CPT® codes and their current Medicare reimbursement rates, see the 2025 Canary Speech Reimbursement Guide: https://na2.hubs.ly/H02LSV80.
- https://www.neurology.columbia.edu/news/one-10-older-americans-has-dementia#:~:text=22%25%20have%20mild%20cognitive%20impairment ↩︎
- https://link.springer.com/article/10.14283/jpad.2024.68#:~:text=Out%20of%20the,34599%20vs%20%2424541%3B ↩︎
- https://pubmed.ncbi.nlm.nih.gov/36279130/https://pubmed.ncbi.nlm.nih.gov/36279130/ ↩︎
- https://canaryspeech.com/blog/the-future-of-healthcare-is-sounding-different/ ↩︎
CPT® codes, descriptions, and other data only are copyright 2025 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
No fee schedules, basic unit, relative values, or related listings are included in CPT. The AMA assumes no liability for any consequences attributable to use of CPT or interpretation of this information. The AMA does not endorse or recommend any specific use, practice, or reimbursement outcome. All responsibility for content lies exclusively with Company Name.
Use of CPT in this publication is authorized by license from the AMA.
For further questions regarding coding or reimbursement, please contact your payer or the AMA.





